US 8507463
Nucleotide analogue prodrug and the preparation thereof
granted A61KA61K31/675A61K9/0019
Quick answer
US patent 8507463 (Nucleotide analogue prodrug and the preparation thereof) held by BrightGene Bio-Medical Technology Co., Ltd. expires Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BrightGene Bio-Medical Technology Co., Ltd.
- Grant date
- Tue Aug 13 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K31/675, A61K9/0019, A61K9/0056, A61K9/2009